Updates

These updates includes material published by third parties and compiled by PAHO. PAHO has taken reasonable precautions to verify the information contained in the document. However, this material is being distributed without warranty of any kind. The reader is responsible for the interpretation and use of this information and in no event shall PAHO be held liable for any damages arising from its use.
  • Updates
  • Official reports from pharmacovigilance programs
  • Clarifications/conclusions of events presented in previous communications
  • Other related updates
04/27/2021

GACVS: Review of rare adverse blood clotting events with AstraZeneca COVID-19 vaccine (Vaxzevria and Covishield)

On 16 April 2021, the World Health Organization (WHO) published conclusions from the Global Advisory Committee on Vaccine Safety (GACVS) review of the latest evidence related to reports of rare adverse events following immunization with the AstraZeneca COVID-19 vaccine (Vaxzevria and Covishield).

Read more
04/19/2021

Review of rare blood-clotting adverse events with the AstraZeneca COVID-19 vaccine (Vaxzevria and Covishield)

by the World Health Organization's Global Advisory Committee on Vaccine Safety

Read more